Search
|
Schedule
|
Concurrent Oral Session Grid
|
Author Index
|
eBook
|
Personal Scheduler
Jasvinder Gill, MD
Sanofi US, Inc.
Papers:
MUCH ADO ABOUT NOTHING? A LONGITUDINAL RETROSPECTIVE STUDY OF PATIENTS WITH TYPE-2 DIABETES TREATED WITH INSULIN GLARGINE AND SWITCHED TO INSULIN DETEMIR
